Skip to main content

Together we are beating cancer

Donate now

Cancer News

Improving treatments

Showing 12 out of 41 results
An image of a radiotherapy machine. Its lights are glowing blue.

Based on our research, NHS England will use stereotactic ablative radiotherapy (SABR) to treat many early-stage prostate cancers in five sessions, rather than 20.  Based on our research, NHS England will use stereotactic ablative radiotherapy (SABR) to treat many early-stage prostate cancers in five sessions, rather than 20. 

by Tim Gunn | News | 17 June 2026

17 June 2026

A group of microscopic glioblastoma cells against a black background. The cells are coloured red, with their steroid receptors marked in green.

Our researchers have found that steroids, vital tools for managing brain tumour symptoms, could also make glioblastomas vulnerable to a special diet. Our researchers have found that steroids, vital tools for managing brain tumour symptoms, could also make glioblastomas vulnerable to a special diet.

by Fiona MacLeod, Tim Gunn | Analysis | 20 February 2026

20 February 2026

A microscopic image showing a tumour sample with different types of cells in different colours. Macrophages (red) are producing HO-1 near blood vessels (green) to keep T cells out of tumour tissue. Many of the blue cells in this image are cancer cells. There are small pockets of T cells highlighted in magenta.

KCL-HO-1i, a new type of chemotherapy "companion drug" that can be taken as a daily pill, could pave the way to more effective cancer treatments with fewer side effects. KCL-HO-1i, a new type of chemotherapy "companion drug" that can be taken as a daily pill, could pave the way to more effective cancer treatments with fewer side effects.

by Tim Gunn | Analysis | 4 November 2025

4 November 2025

A group of killer T cells (green and red) surrounding a cancer cell (blue, center).

Our researchers are using donated immune cells to make one of the most advanced and specialised treatments for childhood blood cancers more accessible and effective. Our researchers are using donated immune cells to make one of the most advanced and specialised treatments for childhood blood cancers more accessible and effective.

by Seren Limb | Analysis | 29 September 2025

29 September 2025

A computer graphic showing three researchers working in a lab. Above them are three white bubbles howing the bacteria in the gut microbiome, a 'drug made from a bug' and cancer cells being targeted by immune cells.

By studying how the bacteria in our guts can affect the immune system, our researchers have found a potential way to treat melanoma with 'drugs made from bugs'. By studying how the bacteria in our guts can affect the immune system, our researchers have found a potential way to treat melanoma with 'drugs made from bugs'.

by Helen Renshaw | Analysis | 22 July 2025

22 July 2025

A breast cancer cell seen through an electron microscope.

Our Partner trial has found a new treatment combination for women with inherited breast cancers, with all 39 patients who received it surviving the critical three years after surgery Our Partner trial has found a new treatment combination for women with inherited breast cancers, with all 39 patients who received it surviving the critical three years after surgery

by Amal Iman, Tim Gunn | News | 13 May 2025

13 May 2025

A microscope image showing immune cells in bowel cancer.

A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects. A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects.

by Sadaf Shafaghmotlagh, Tim Gunn | Analysis | 27 January 2025

27 January 2025

An illustration of a T cell

With help from a new Nobel Laureate, Cancer Grand Challenges team MATCHMAKERS are developing AI models that can identify the immune cells best equipped to fight different cancers. That should make it possible to improve immunotherapies and match patients with the treatments best suited to them as individuals. With help from a new Nobel Laureate, Cancer Grand Challenges team MATCHMAKERS are developing AI models that can identify the immune cells best equipped to fight different cancers. That should make it possible to improve immunotherapies and match patients with the treatments best suited to them as individuals.

by Jacob Smith | Analysis | 31 October 2024

31 October 2024

A magnified image of squamous cell carcinoma, the most common type of cervical cancer.

Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs.  Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs. 

by Sophie Wedekind | 14 October 2024

14 October 2024